Replimune Group, Inc.
US ˙ NasdaqGS ˙ US76029N1063

Introduzione

Questa pagina fornisce un'analisi completa dello storico delle operazioni di insider trading note di Jason P Rhodes. Gli insider sono funzionari, direttori o investitori importanti di una società. In generale, è illegale per gli insider effettuare operazioni di compravendita nelle loro aziende sulla base di informazioni materiali non pubbliche. Ciò non significa che sia illegale per loro effettuare qualsiasi operazioni di trading nelle proprie aziende. Tuttavia, devono segnalare tutte le operazioni alla SEC tramite un modulo 4. Nonostante queste restrizioni, la ricerca accademica suggerisce che gli insider, in generale, tendono a sovraperformare il mercato nelle proprie società.

Redditività media delle transazioni

La redditività media delle transazioni è il rendimento medio di tutti gli acquisti effettuati sul mercato aperto dagli insider negli ultimi tre anni. Pe calcolarla, esaminiamo tutti gli acquisti non pianificati effettuati dall'insider sul mercato aperto, escludendo tutte le operazioni che sono state parte di un piano di trading 10b5-1. Calcoliamo quindi la performance media di queste operazioni nell'arco di 3, 6 e 12 mesi e facciamo la media di ciascuna di queste durate per generare un indicatore di performance finale per ogni operazione. Infine, facciamo la media di tutti gli indicatori di performance per calcolare un indicatore di performance per l'insider. Questo elenco comprende solo gli insider che hanno effettuato almeno tre operazioni negli ultimi due anni.

Se la redditività delle operazioni di questo insider è "N/D", l'insider non ha effettuato acquisti sul mercato aperto negli ultimi tre anni, oppure le operazioni effettuate sono troppo recenti per poter calcolare un indicatore di performance affidabile.

Frequenza di aggiornamento: giornaliera

Vedi l'elenco degli insider trader più redditizi

Società con posizioni di insider dichiarate

I depositi SEC indicano che Jason P Rhodes ha dichiarato partecipazioni o transazioni nelle seguenti società:

Titolo Ruolo Ultime partecipazioni dichiarate
Director 1.136.810
US:GBIO / Generation Bio Co. Director 0
US:REPL / Replimune Group, Inc. Director 16.500
US:GMTX / Gemini Therapeutics Inc Director, 10% Owner 17.245
US:EPZM / Epizyme Inc President, CFO and Treasurer 149.459
Come interpretare i grafici

I grafici seguenti mostrano l'andamento dei titoli dopo ogni operazione di mercato aperto non pianificata effettuata da Jason P Rhodes. Per operazioni non pianificate si intendono operazioni non effettuate nell'ambito di un piano di trading 10b5-1. La performance dei titoli è rappresentata come variazione percentuale cumulativa del prezzo delle azioni. Ad esempio, se un'operazione di insider è stata effettuata il 1° gennaio 2019, il grafico mostrerà la variazione percentuale giornaliera del titolo fino ad oggi. Se il prezzo dell'azione passasse da 10 a 15 dollari durante questo periodo, la variazione percentuale cumulativa del prezzo dell'azione sarebbe del 50%. Una variazione di prezzo da 10 a 20 dollari sarebbe del 100%, mentre una variazione di prezzo da 10 a 5 dollari sarebbe del -50%.

In definitiva, cerchiamo di determinare la correlazione tra le operazioni dell'insider e i rendimenti in eccesso (positivi o negativi) del prezzo dell'azione, al fine di capire se l'insider sta programmando le proprie operazioni per trarre profitto da informazioni privilegiate. Immaginiamo che un insider stia facendo questo. In questa situazione, ci aspetteremmo (a) rendimenti positivi dopo gli acquisti, oppure (b) rendimenti negativi dopo le vendite. Nel caso (a), il grafico ACQUISTO mostrerebbe una serie di curve ascendenti, indicando rendimenti positivi dopo ogni operazione di acquisto. Nel caso (b), il grafico VENDITA mostrerebbe una serie di curve inclinate verso il basso, indicando rendimenti negativi dopo ogni operazione di vendita.

Tuttavia, questo non è sufficiente per trarre conclusioni. Se, ad esempio, il prezzo delle azioni della società è aumentato in maniera non ciclica per molti anni, allora ci aspetteremmo che tutti i grafici post-acquisto abbiano una pendenza rivolta verso l'alto. Allo stesso modo, ribassi non ciclici per molti anni darebbero luogo a grafici post-negoziazione rivolti verso il basso. Nessuno di questi grafici suggerisce un'attività di insider trading.

L'indicatore più forte sarebbe una situazione in cui il prezzo delle azioni fosse estremamente ciclico e vi fossero segnali positivi nel grafico ACQUISTO e curve negative nel grafico VENDITA. Questa situazione suggerirebbe che l'insider sta programmando le operazioni di trading per trarne un vantaggio finanziario.

Acquisti di insider REPL / Replimune Group, Inc. - Analisi degli utili a breve termine

In questa sezione analizziamo la redditività di ogni acquisto non pianificato di insider sul mercato aperto effettuato in REPL / Replimune Group, Inc.. Questa analisi aiuta a capire se l'insider genera costantemente rendimenti anomali e se vale la pena seguirlo. L'analisi riguarda l'anno successivo a ciascuna operazione, e i risultati sono teorici.

La tabella seguente mostra gli acquisti più recenti sul mercato aperto che non facevano parte di un piano di trading automatico.

Data dell'operazione Ticker Insider Azioni
dichiarate
Prezzo
dichiarato
Azioni
rettificate
Prezzo
rettificato
Base di costo Giorni fino al
massimo
Prezzo al
massimo
Profitto
massimo ($)
Rendimento massimo (%)
2019-11-18 REPL Rhodes Jason P 1.100.000 13,6100 1.100.000 13,6100 14.971.000 365 48.9100 38.830.000 259,37

Il prezzo rettificato è il prezzo rettificato per il frazionamento azionario. Leazioni rettificate sono le azioni rettificate per il frazionamento azionario.

REPL / Replimune Group, Inc. Insider Trades
Vendite di insider REPL / Replimune Group, Inc. - Analisi delle perdite a breve termine

In questa sezione, analizziamo l'evitamento delle perdite a breve termine di ogni vendita di insider non pianificata ed effettuata sul mercato aperto in REPL / Replimune Group, Inc.. Un modello coerente di evitamento delle perdite può suggerire che future transazioni di vendita potrebbero predire cali di prezzo. L'analisi riguarda l'anno successivo a ciascuna operazione, e i risultati sono teorici.

La tabella seguente mostra le vendite più recenti sul mercato aperto che non facevano parte di un piano di trading automatico.

Data dell'operazione Ticker Insider Azioni
dichiarate
Prezzo
dichiarato
Azioni
rettificate
Prezzo
rettificato
Base di costo Giorni fino al
minimo
Prezzo al
minimo
Perdita massima
evitata ($)
Perdita massima
evitata (%)
Non sono note operazioni di mercato aperto non pianificate per questa combinazione di insider e titoli.

Il prezzo rettificato è il prezzo rettificato per il frazionamento azionario. Leazioni rettificate sono le azioni rettificate per il frazionamento azionario.

REPL / Replimune Group, Inc. Insider Trades
Storico delle operazioni degli insider

Questa tabella mostra l'elenco completo delle operazioni effettuate da Jason P Rhodes come comunicato alla Securities Exchange Commission (SEC).

Data di deposito Data della transazione Modulo Ticker Titolo Codice 10b5-1 Azioni Azioni rimanenti Variazione
percentuale
Prezzo
dell'azione
Valore
della transazione
Valore
rimanente
2026-05-06 2026-05-06 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -17.244 1.136.810 -1,49 18,18 -313.496 20.667.206
2026-05-06 2026-05-06 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -428 7.962 -5,10 18,18 -7.781 144.749
2026-05-06 2026-05-06 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -43.621 4.883.494 -0,89 18,18 -793.030 88.781.921
2026-05-06 2026-05-06 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -21.926 1.549.288 -1,40 18,18 -398.615 28.166.056
2026-05-06 2026-05-05 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -2.403 1.154.054 -0,21 18,03 -43.326 20.807.594
2026-05-06 2026-05-05 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -60 8.390 -0,71 18,03 -1.082 151.272
2026-05-06 2026-05-05 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -6.081 4.927.115 -0,12 18,03 -109.640 88.835.883
2026-05-06 2026-05-05 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -3.056 1.571.214 -0,19 18,03 -55.100 28.328.988
2026-05-06 2026-05-04 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -2.466 1.156.457 -0,21 18,00 -44.388 20.816.226
2026-05-06 2026-05-04 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -61 8.450 -0,72 18,00 -1.098 152.100
2026-05-06 2026-05-04 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -6.241 4.933.196 -0,13 18,00 -112.338 88.797.528
2026-05-06 2026-05-04 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -3.136 1.574.270 -0,20 18,00 -56.448 28.336.860
2026-04-30 2026-04-28 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -21 1.158.923 0,00 19,00 -399 22.019.537
2026-04-30 2026-04-28 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -1 8.511 -0,01 19,00 -19 161.709
2026-04-30 2026-04-28 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -52 4.939.437 0,00 19,00 -988 93.849.303
2026-04-30 2026-04-28 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -26 1.577.406 0,00 19,00 -494 29.970.714
2026-04-30 2026-04-28 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -47.082 1.158.944 -3,90 18,38 -865.367 21.301.391
2026-04-30 2026-04-28 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -1.170 8.512 -12,08 18,38 -21.505 156.451
2026-04-30 2026-04-28 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -119.115 4.939.489 -2,35 18,38 -2.189.334 90.787.808
2026-04-30 2026-04-28 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -59.870 1.577.432 -3,66 18,38 -1.100.411 28.993.200
2026-04-27 2026-04-27 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -35.947 1.206.026 -2,89 18,15 -652.438 21.889.372
2026-04-27 2026-04-27 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -894 9.682 -8,45 18,15 -16.226 175.728
2026-04-27 2026-04-27 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -90.943 5.058.604 -1,77 18,15 -1.650.615 91.813.663
2026-04-27 2026-04-27 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -45.709 1.637.302 -2,72 18,15 -829.618 29.717.031
2026-04-27 2026-04-24 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -28.583 1.241.973 -2,25 18,48 -528.214 22.951.661
2026-04-27 2026-04-24 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -710 10.576 -6,29 18,48 -13.121 195.444
2026-04-27 2026-04-24 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -72.310 5.149.547 -1,38 18,48 -1.336.289 95.163.629
2026-04-27 2026-04-24 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -36.345 1.683.011 -2,11 18,48 -671.656 31.102.043
2026-04-27 2026-04-23 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -15.148 1.270.556 -1,18 19,19 -290.690 24.381.970
2026-04-27 2026-04-23 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -377 11.286 -3,23 19,19 -7.235 216.578
2026-04-27 2026-04-23 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -38.322 5.221.857 -0,73 19,19 -735.399 100.207.436
2026-04-27 2026-04-23 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -19.261 1.719.356 -1,11 19,19 -369.619 32.994.442
2026-04-22 2026-04-22 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -59.663 1.285.704 -4,43 19,68 -1.174.168 25.302.655
2026-04-22 2026-04-22 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -1.485 11.663 -11,29 19,68 -29.225 229.528
2026-04-22 2026-04-22 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -150.942 5.260.179 -2,79 19,68 -2.970.539 103.520.323
2026-04-22 2026-04-22 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -75.866 1.738.617 -4,18 19,68 -1.493.043 34.215.983
2026-04-22 2026-04-21 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -605 1.345.367 -0,04 20,05 -12.130 26.974.608
2026-04-22 2026-04-21 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -15 13.148 -0,11 20,05 -301 263.617
2026-04-22 2026-04-21 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -1.530 5.411.121 -0,03 20,05 -30.676 108.492.976
2026-04-22 2026-04-21 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -769 1.814.483 -0,04 20,05 -15.418 36.380.384
2026-04-22 2026-04-21 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -56.228 1.345.972 -4,01 19,51 -1.097.008 26.259.914
2026-04-22 2026-04-21 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -1.398 13.163 -9,60 19,51 -27.275 256.810
2026-04-22 2026-04-21 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -142.253 5.412.651 -2,56 19,51 -2.775.356 105.600.821
2026-04-22 2026-04-21 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -71.499 1.815.252 -3,79 19,51 -1.394.945 35.415.567
2026-04-22 2026-04-20 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -56.368 1.402.200 -3,86 20,06 -1.130.742 28.128.132
2026-04-22 2026-04-20 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -1.401 14.561 -8,78 20,06 -28.104 292.094
2026-04-22 2026-04-20 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -142.604 5.554.904 -2,50 20,06 -2.860.636 111.431.374
2026-04-22 2026-04-20 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -71.676 1.886.751 -3,66 20,06 -1.437.821 37.848.225
2026-02-09 2026-02-09 4 GBIO Generation Bio Co.
Common Stock
U - Other -60 0 -100,00
2026-02-09 2026-02-09 4 GBIO Generation Bio Co.
Common Stock
U - Other -116.693 0 -100,00
2026-02-09 2026-02-09 4 GBIO Generation Bio Co.
Common Stock
U - Other -711.193 0 -100,00
2025-01-29 2025-01-27 4 DYN Dyne Therapeutics, Inc.
Common Stock
A - Award 1.111.111 1.958.427 131,13 13,50 14.999.998 26.438.764
2024-11-18 2024-11-14 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale -72 847.316 -0,01 33,10 -2.383 28.046.160
2024-11-18 2024-11-14 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale -123 1.458.568 -0,01 33,10 -4.071 48.278.601
2024-11-18 2024-11-14 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale -4 15.962 -0,03 33,10 -132 528.342
2024-11-18 2024-11-14 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale -583 5.697.508 -0,01 33,10 -19.297 188.587.515
2024-03-05 2024-03-01 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -17.099 847.388 -1,98 30,05 -513.825 25.464.009
2024-03-05 2024-03-01 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -29.435 1.458.691 -1,98 30,05 -884.522 43.833.665
2024-02-28 2024-02-28 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -210 864.487 -0,02 25,25 -5.302 21.828.297
2024-02-28 2024-02-28 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -13.109 864.697 -1,49 24,83 -325.496 21.470.427
2024-02-28 2024-02-28 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -360 1.488.126 -0,02 25,25 -9.090 37.575.182
2024-02-28 2024-02-28 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -22.567 1.488.486 -1,49 24,83 -560.339 36.959.107
2024-02-28 2024-02-28 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -2.430 5.698.091 -0,04 25,25 -61.358 143.876.798
2024-02-28 2024-02-28 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -152.244 5.700.521 -2,60 24,83 -3.780.219 141.543.936
2024-02-28 2024-02-27 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -2.216 877.806 -0,25 24,68 -54.691 21.664.252
2024-02-28 2024-02-27 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -23.505 880.022 -2,60 24,38 -573.052 21.454.936
2024-02-28 2024-02-27 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -3.821 1.511.053 -0,25 24,68 -94.302 37.292.788
2024-02-28 2024-02-27 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -40.455 1.514.874 -2,60 24,38 -986.293 36.932.628
2024-02-28 2024-02-27 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -25.779 5.852.765 -0,44 24,68 -636.226 144.446.240
2024-02-28 2024-02-27 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -272.923 5.878.544 -4,44 24,38 -6.653.863 143.318.903
2024-02-28 2024-02-26 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -5.580 903.527 -0,61 23,98 -133.808 21.666.577
2024-02-28 2024-02-26 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -11.736 909.107 -1,27 23,59 -276.852 21.445.834
2024-02-28 2024-02-26 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -9.603 1.555.329 -0,61 23,98 -230.280 37.296.789
2024-02-28 2024-02-26 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -20.205 1.564.932 -1,27 23,59 -476.636 36.916.746
2024-02-28 2024-02-26 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -64.783 6.151.467 -1,04 23,98 -1.553.496 147.512.179
2024-02-28 2024-02-26 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -136.312 6.216.250 -2,15 23,59 -3.215.600 146.641.338
2024-02-23 2024-02-23 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -13.738 920.843 -1,47 22,70 -311.853 20.903.136
2024-02-23 2024-02-23 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -23.648 1.585.137 -1,47 22,70 -536.810 35.982.610
2024-02-23 2024-02-23 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -159.542 6.352.562 -2,45 22,70 -3.621.603 144.203.157
2024-02-23 2024-02-22 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -119.360 6.512.104 -1,80 22,66 -2.704.698 147.564.277
2024-02-23 2024-02-21 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -35.164 6.631.464 -0,53 23,14 -813.695 153.452.077
2024-02-23 2024-02-21 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -149.337 6.666.628 -2,19 22,44 -3.351.122 149.599.132
2024-02-20 2024-02-20 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -3.510 6.815.965 -0,05 23,40 -82.134 159.493.581
2024-02-20 2024-02-20 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -166.029 6.819.475 -2,38 22,71 -3.770.519 154.870.277
2024-02-20 2024-02-16 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -162.707 6.985.504 -2,28 23,14 -3.765.040 161.644.563
2024-02-20 2024-02-15 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -2.113 7.148.211 -0,03 24,45 -51.663 174.773.759
2024-02-20 2024-02-15 4 DYN Dyne Therapeutics, Inc.
Common Stock
S - Sale X -175.793 7.150.324 -2,40 23,88 -4.197.937 170.749.737
2022-12-14 2022-12-12 4 DYN Dyne Therapeutics, Inc.
Common Stock
P - Purchase 934.581 934.581 10,70 10.000.017 10.000.017
2022-04-05 2022-04-01 4 REPL Replimune Group, Inc.
Stock Option (right to buy)
A - Award 16.500 16.500
2021-10-06 2021-10-04 4 GMTX Gemini Therapeutics, Inc. /DE
Stock Option (Right to Buy)
A - Award 17.245 17.245
2021-09-29 2021-09-29 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -30 608 -4,70 24,59 -738 14.951
2021-09-29 2021-09-29 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -16.556 0 -100,00 24,59 -407.112
2021-09-29 2021-09-28 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -24 638 -3,63 25,24 -606 16.103
2021-09-29 2021-09-28 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -13.089 16.556 -44,15 25,24 -330.366 417.873
2021-09-29 2021-09-27 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -95 662 -12,55 25,70 -2.442 17.013
2021-09-29 2021-09-27 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -51.294 29.645 -63,37 25,70 -1.318.256 761.876
2021-09-24 2021-09-24 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -54 757 -6,66 25,84 -1.395 19.560
2021-09-24 2021-09-24 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -28.862 80.939 -26,29 25,84 -745.765 2.091.383
2021-09-24 2021-09-23 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -140 811 -14,72 26,13 -3.659 21.194
2021-09-24 2021-09-23 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -1 109.801 0,00 26,55 -27 2.915.217
2021-09-24 2021-09-23 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -75.324 109.802 -40,69 26,13 -1.968.442 2.869.456
2021-09-24 2021-09-22 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -57 951 -5,65 25,89 -1.476 24.622
2021-09-24 2021-09-22 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -30.560 185.126 -14,17 25,89 -791.229 4.793.097
2021-06-28 2021-06-24 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -8 608 -1,30 26,39 -211 16.045
2021-06-28 2021-06-24 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -50 616 -7,51 25,77 -1.288 15.874
2021-06-28 2021-06-24 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -4.092 0 -100,00 26,39 -107.988
2021-06-28 2021-06-24 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -26.858 4.092 -86,78 25,77 -692.131 105.451
2021-06-23 2021-06-23 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -53 666 -7,37 25,69 -1.362 17.110
2021-06-23 2021-06-23 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -63 719 -8,06 25,08 -1.580 18.033
2021-06-23 2021-06-23 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -28.331 30.950 -47,79 25,69 -727.823 795.106
2021-06-23 2021-06-23 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -34.162 59.281 -36,56 25,08 -856.783 1.486.767
2021-06-23 2021-06-22 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -47 782 -5,67 25,20 -1.184 19.706
2021-06-23 2021-06-22 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -61 829 -6,85 24,76 -1.510 20.526
2021-06-23 2021-06-22 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -25.208 93.443 -21,25 25,20 -635.242 2.354.764
2021-06-23 2021-06-22 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -33.261 118.651 -21,89 24,76 -823.542 2.937.799
2021-06-23 2021-06-21 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -7 890 -0,78 25,12 -176 22.357
2021-06-23 2021-06-21 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -111 897 -11,01 24,82 -2.755 22.264
2021-06-23 2021-06-21 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -3.796 151.912 -2,44 25,12 -95.356 3.816.029
2021-06-23 2021-06-21 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -59.978 155.708 -27,81 24,82 -1.488.654 3.864.673
2021-06-11 2021-06-09 4 GBIO Generation Bio Co.
Stock Option (right to buy)
A - Award 15.000 15.000
2021-05-27 2021-05-26 4 DYN Dyne Therapeutics, Inc.
Stock Option (right to buy)
A - Award 19.596 19.596
2021-04-14 2021-04-14 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -12.874 0 -100,00 26,78 -344.766
2021-04-14 2021-04-14 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -10.539 12.874 -45,01 26,40 -278.230 339.874
2021-04-14 2021-04-13 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -7.354 23.413 -23,90 25,53 -187.748 597.734
2021-04-14 2021-04-13 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -35.791 30.767 -53,77 25,09 -897.996 771.944
2021-04-14 2021-04-12 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -10.771 66.558 -13,93 26,61 -286.616 1.771.108
2021-04-14 2021-04-12 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -63.353 77.329 -45,03 26,07 -1.651.613 2.015.967
2021-04-09 2021-04-09 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -2.132 140.682 -1,49 28,35 -60.442 3.988.335
2021-04-09 2021-04-09 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -41.549 142.814 -22,54 27,57 -1.145.506 3.937.382
2021-04-09 2021-04-08 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -3.191 184.363 -1,70 28,90 -92.220 5.328.091
2021-04-09 2021-04-08 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -40.359 187.554 -17,71 28,47 -1.149.021 5.339.662
2021-04-09 2021-04-07 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -1.894 227.913 -0,82 29,19 -55.286 6.652.780
2021-04-09 2021-04-07 4 GBIO Generation Bio Co.
Common Stock
S - Sale X -37.970 229.807 -14,18 28,48 -1.081.386 6.544.903
2021-04-05 2021-04-01 4 REPL Replimune Group, Inc.
Stock Option (right to buy)
A - Award 16.500 16.500
2021-02-11 3 GMTX Gemini Therapeutics, Inc. /DE
Common Stock
4.015.045
2021-02-11 3 GMTX Gemini Therapeutics, Inc. /DE
Common Stock
729.320
2021-02-11 3 GMTX Gemini Therapeutics, Inc. /DE
Common Stock
510.000
2021-01-28 2021-01-26 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -5.558 946.000 -0,58 46,14 -256.446 43.648.440
2020-12-22 2020-12-18 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -265 19.285 -1,36 41,95 -11.117 809.006
2020-12-22 2020-12-18 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -1.042 951.558 -0,11 41,95 -43.712 39.917.858
2020-12-22 2020-12-18 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -3.012 2.263.627 -0,13 41,95 -126.353 94.959.153
2020-12-17 2020-12-17 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -697 19.550 -3,44 42,00 -29.274 821.100
2020-12-17 2020-12-17 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -2.785 952.600 -0,29 42,00 -116.970 40.009.200
2020-12-17 2020-12-17 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -8.053 2.266.639 -0,35 42,00 -338.226 95.198.838
2020-12-17 2020-12-16 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -766 20.247 -3,65 42,13 -32.272 853.006
2020-12-17 2020-12-16 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -3.060 955.385 -0,32 42,13 -128.918 40.250.370
2020-12-17 2020-12-16 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -8.849 2.274.692 -0,39 42,13 -372.808 95.832.774
2020-12-17 2020-12-15 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -6 21.013 -0,03 44,08 -264 926.253
2020-12-17 2020-12-15 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -30 21.019 -0,14 43,12 -1.294 906.339
2020-12-17 2020-12-15 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -2.432 21.049 -10,36 42,40 -103.117 892.478
2020-12-17 2020-12-15 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -24 958.445 0,00 44,08 -1.058 42.248.256
2020-12-17 2020-12-15 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -120 958.469 -0,01 43,12 -5.174 41.329.183
2020-12-17 2020-12-15 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -9.710 958.589 -1,00 42,40 -411.704 40.644.174
2020-12-17 2020-12-15 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -70 2.283.541 0,00 44,08 -3.086 100.658.487
2020-12-17 2020-12-15 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -349 2.283.611 -0,02 43,12 -15.049 98.469.306
2020-12-17 2020-12-15 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -28.078 2.283.960 -1,21 42,40 -1.190.507 96.839.904
2020-12-14 2020-12-14 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -181 23.481 -0,76 44,06 -7.975 1.034.573
2020-12-14 2020-12-14 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -1.855 23.662 -7,27 43,54 -80.767 1.030.243
2020-12-14 2020-12-14 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -240 25.517 -0,93 42,69 -10.246 1.089.321
2020-12-14 2020-12-14 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -722 968.299 -0,07 44,06 -31.811 42.663.254
2020-12-14 2020-12-14 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -7.409 969.021 -0,76 43,54 -322.588 42.191.174
2020-12-14 2020-12-14 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -961 976.430 -0,10 42,69 -41.025 41.683.797
2020-12-14 2020-12-14 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -2.087 2.312.038 -0,09 44,06 -91.953 101.868.394
2020-12-14 2020-12-14 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -21.428 2.314.125 -0,92 43,54 -932.975 100.757.002
2020-12-14 2020-12-14 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -2.776 2.335.553 -0,12 42,69 -118.507 99.704.758
2020-12-14 2020-12-11 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -205 25.757 -0,79 43,92 -9.004 1.131.247
2020-12-14 2020-12-11 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -1.707 25.962 -6,17 43,32 -73.947 1.124.674
2020-12-14 2020-12-11 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -821 977.391 -0,08 43,92 -36.058 42.927.013
2020-12-14 2020-12-11 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -6.817 978.212 -0,69 43,32 -295.312 42.376.144
2020-12-14 2020-12-11 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -2.374 2.338.329 -0,10 43,92 -104.266 102.699.410
2020-12-14 2020-12-11 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -19.712 2.340.703 -0,84 43,32 -853.924 101.399.254
2020-12-14 2020-12-10 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -230 27.669 -0,82 44,35 -10.200 1.227.120
2020-12-14 2020-12-10 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -750 27.899 -2,62 43,48 -32.610 1.213.049
2020-12-14 2020-12-10 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -1.099 28.649 -3,69 42,68 -46.905 1.222.739
2020-12-14 2020-12-10 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -917 985.029 -0,09 44,35 -40.669 43.686.036
2020-12-14 2020-12-10 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -2.996 985.946 -0,30 43,48 -130.266 42.868.932
2020-12-14 2020-12-10 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -4.389 988.942 -0,44 42,68 -187.323 42.208.045
2020-12-14 2020-12-10 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -2.653 2.360.415 -0,11 44,35 -117.661 104.684.405
2020-12-14 2020-12-10 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -8.666 2.363.068 -0,37 43,48 -376.798 102.746.197
2020-12-14 2020-12-10 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -12.691 2.371.734 -0,53 42,68 -541.652 101.225.607
2020-12-09 2020-12-09 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -151 29.748 -0,51 45,32 -6.843 1.348.179
2020-12-09 2020-12-09 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -635 29.899 -2,08 44,69 -28.378 1.336.186
2020-12-09 2020-12-09 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -1.549 30.534 -4,83 43,36 -67.165 1.323.954
2020-12-09 2020-12-09 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -151 32.083 -0,47 42,51 -6.419 1.363.848
2020-12-09 2020-12-09 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -100 993.331 -0,01 46,47 -4.647 46.160.092
2020-12-09 2020-12-09 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -604 993.431 -0,06 45,32 -27.373 45.022.293
2020-12-09 2020-12-09 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -2.535 994.035 -0,25 44,69 -113.289 44.423.424
2020-12-09 2020-12-09 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -6.183 996.570 -0,62 43,36 -268.095 43.211.275
2020-12-09 2020-12-09 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -603 1.002.753 -0,06 42,51 -25.634 42.627.030
2020-12-09 2020-12-09 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -1.747 2.384.425 -0,07 45,32 -79.174 108.062.141
2020-12-09 2020-12-09 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -7.330 2.386.172 -0,31 44,69 -327.578 106.638.027
2020-12-09 2020-12-09 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -17.883 2.393.502 -0,74 43,36 -775.407 103.782.247
2020-12-09 2020-12-09 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -1.745 2.411.385 -0,07 42,51 -74.180 102.507.976
2020-12-09 2020-12-08 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -2.869 32.234 -8,17 46,94 -134.671 1.513.064
2020-12-09 2020-12-08 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -606 35.103 -1,70 46,02 -27.888 1.615.440
2020-12-09 2020-12-08 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -45.027 1.003.356 -4,29 46,89 -2.111.316 47.047.363
2020-12-09 2020-12-08 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -19.620 1.048.383 -1,84 46,14 -905.267 48.372.392
2020-12-09 2020-12-08 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -33.133 2.413.130 -1,35 46,94 -1.555.263 113.272.322
2020-12-09 2020-12-08 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -7.001 2.446.263 -0,29 46,02 -322.186 112.577.023
2020-12-09 2020-12-07 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -106 35.709 -0,30 46,91 -4.972 1.675.109
2020-12-09 2020-12-07 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -2.007 35.815 -5,31 45,97 -92.262 1.646.416
2020-12-09 2020-12-07 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -748 37.822 -1,94 45,46 -34.004 1.719.388
2020-12-09 2020-12-07 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -2.322 1.068.003 -0,22 46,93 -108.971 50.121.381
2020-12-09 2020-12-07 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -26.713 1.070.325 -2,44 46,06 -1.230.401 49.299.170
2020-12-09 2020-12-07 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -2.962 1.097.038 -0,27 45,45 -134.623 49.860.377
2020-12-09 2020-12-07 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -1.222 2.453.264 -0,05 46,91 -57.324 115.082.614
2020-12-09 2020-12-07 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -23.174 2.454.486 -0,94 45,97 -1.065.309 112.832.721
2020-12-09 2020-12-07 4 REPL Replimune Group, Inc.
Common Stock
S - Sale X -8.636 2.477.660 -0,35 45,46 -392.593 112.634.424
2020-09-23 2020-09-21 4 DYN Dyne Therapeutics, Inc.
Series B Preferred Stock
C - Conversion -5.336.179 0 -100,00
2020-09-23 2020-09-21 4 DYN Dyne Therapeutics, Inc.
Series A Preferred Stock
C - Conversion -20.000.000 0 -100,00
2020-09-23 2020-09-21 4 DYN Dyne Therapeutics, Inc.
Common Stock
C - Conversion 1.608.785 1.608.785
2020-09-23 2020-09-21 4 DYN Dyne Therapeutics, Inc.
Common Stock
C - Conversion 6.029.726 8.140.130 285,71
2020-09-16 3 DYN Dyne Therapeutics, Inc.
Common Stock
2.110.404
2020-06-18 2020-06-16 4 GBIO Generation Bio Co.
Series C Preferred Stock
C - Conversion -2.683 0 -100,00
2020-06-18 2020-06-16 4 GBIO Generation Bio Co.
Series A Preferred Stock
C - Conversion -15.051.020 0 -100,00
2020-06-18 2020-06-16 4 GBIO Generation Bio Co.
Common Stock
C - Conversion 10.040.032 12.630.758 387,54
2020-06-15 2020-06-11 4 GBIO Generation Bio Co.
Stock Option (right to buy)
A - Award 52.000 52.000
2020-06-11 3 GBIO Generation Bio Co.
Common Stock
5.181.452
2020-06-11 3 GBIO Generation Bio Co.
Common Stock
5.181.452
2020-06-11 3 GBIO Generation Bio Co.
Common Stock
5.181.452
2020-04-02 2020-04-01 4 REPL Replimune Group, Inc.
Stock Option (right to buy)
A - Award 16.500 16.500
2019-11-20 2019-11-18 4 REPL Replimune Group, Inc.
Common Stock
P - Purchase 1.100.000 1.100.000 13,61 14.971.000 14.971.000
2019-04-03 2019-04-01 4 REPL Replimune Group, Inc.
Stock Option (right to buy)
A - Award 13.500 13.500
2018-07-26 2018-07-24 4 REPL Replimune Group, Inc.
Stock Option (right to buy)
A - Award 13.500 13.500
2018-07-26 2018-07-24 4 REPL Replimune Group, Inc.
Series B Convertible Preferred Stock
C - Conversion -1.013.547 0 -100,00
2018-07-26 2018-07-24 4 REPL Replimune Group, Inc.
Series A Convertible Preferred Stock
C - Conversion -3.439.839 0 -100,00
2018-07-26 2018-07-24 4 REPL Replimune Group, Inc.
Common Stock
C - Conversion 1.013.547 4.453.386 29,46
2018-07-26 2018-07-24 4 REPL Replimune Group, Inc.
Common Stock
C - Conversion 3.439.839 3.439.839
2014-09-24 2014-09-22 4 EPZM Epizyme, Inc.
Stock Option (Right to Buy)
M - Exercise -44.000 149.459 -22,74
2014-09-24 2014-09-22 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001 per share
M - Exercise 44.000 138.000 46,81 0,51 22.440 70.380
2014-09-04 2014-09-02 4 EPZM Epizyme, Inc.
Stock Option (Right to Buy)
M - Exercise X -36.000 34.819 -50,83
2014-09-04 2014-09-02 4 EPZM Epizyme, Inc.
Stock Option (Right to Buy)
M - Exercise X -6.000 188.833 -3,08
2014-09-04 2014-09-02 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001 per share
S - Sale X -5.972 94.000 -5,97 33,89 -202.392 3.185.669
2014-09-04 2014-09-02 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001 per share
S - Sale X -24.028 99.972 -19,38 33,37 -801.771 3.335.886
2014-09-04 2014-09-02 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001 per share
M - Exercise X 36.000 124.000 40,91 0,60 21.600 74.400
2014-09-04 2014-09-02 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001 per share
M - Exercise X 6.000 88.000 7,32 3,54 21.240 311.520
2014-08-05 2014-08-04 4 EPZM Epizyme, Inc.
Stock Option (Right to Buy)
M - Exercise X -34.000 70.819 -32,44
2014-08-05 2014-08-04 4 EPZM Epizyme, Inc.
Stock Option (Right to Buy)
M - Exercise X -8.000 194.833 -3,94
2014-08-05 2014-08-04 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001 per share
S - Sale X -18.400 82.000 -18,33 30,05 -552.898 2.464.002
2014-08-05 2014-08-04 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001 per share
S - Sale X -11.600 100.400 -10,36 29,26 -339.426 2.937.794
2014-08-05 2014-08-04 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001 per share
M - Exercise X 34.000 112.000 43,59 0,60 20.400 67.200
2014-08-05 2014-08-04 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001 per share
M - Exercise X 8.000 78.000 11,43 3,54 28.320 276.120
2014-07-09 2014-07-07 4 EPZM Epizyme, Inc.
Stock Option (Right to Buy)
M - Exercise X -32.000 193.459 -14,19
2014-07-09 2014-07-07 4 EPZM Epizyme, Inc.
Stock Option (Right to Buy)
M - Exercise X -4.000 104.819 -3,68
2014-07-09 2014-07-07 4 EPZM Epizyme, Inc.
Stock Option (Right to Buy)
M - Exercise X -6.000 202.833 -2,87
2014-07-09 2014-07-07 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001 per share
S - Sale X -6.446 70.000 -8,43 33,55 -216.258 2.348.444
2014-07-09 2014-07-07 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001 per share
S - Sale X -23.554 76.446 -23,55 32,52 -765.903 2.485.787
2014-07-09 2014-07-07 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001 per share
M - Exercise X 32.000 100.000 47,06 0,51 16.320 51.000
2014-07-09 2014-07-07 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001 per share
M - Exercise X 4.000 68.000 6,25 0,60 2.400 40.800
2014-07-09 2014-07-07 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001 per share
M - Exercise X 6.000 64.000 10,34 3,54 21.240 226.560
2014-06-04 2014-06-02 4 EPZM Epizyme, Inc.
Stock Option (Right to Buy)
M - Exercise X -27.000 225.459 -10,69
2014-06-04 2014-06-02 4 EPZM Epizyme, Inc.
Stock Option (Right to Buy)
M - Exercise X -15.000 208.833 -6,70
2014-06-04 2014-06-02 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001 per share
S - Sale X -1.264 58.000 -2,13 23,36 -29.529 1.354.967
2014-06-04 2014-06-02 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001 per share
S - Sale X -28.736 59.264 -32,65 22,14 -636.341 1.312.366
2014-06-04 2014-06-02 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001 per share
M - Exercise X 27.000 88.000 44,26 0,51 13.770 44.880
2014-06-04 2014-06-02 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001 per share
M - Exercise X 15.000 61.000 32,61 3,54 53.100 215.940
2014-05-05 2014-05-05 4 EPZM Epizyme, Inc.
Stock Option (Right to Buy)
M - Exercise X -5.000 252.459 -1,94
2014-05-05 2014-05-05 4 EPZM Epizyme, Inc.
Stock Option (Right to Buy)
M - Exercise X -37.000 223.833 -14,19
2014-05-05 2014-05-05 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001 per share
S - Sale X -30.000 46.000 -39,47 21,53 -645.840 990.288
2014-05-05 2014-05-05 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001 per share
M - Exercise X 5.000 76.000 7,04 0,51 2.550 38.760
2014-05-05 2014-05-05 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001 per share
M - Exercise X 37.000 71.000 108,82 3,54 130.980 251.340
2014-04-08 2014-04-07 4 EPZM Epizyme, Inc.
Stock Option (Right to Buy)
M - Exercise X -35.000 257.459 -11,97
2014-04-08 2014-04-07 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001 per share
S - Sale X -25.000 34.000 -42,37 20,05 -501.190 681.618
2014-04-08 2014-04-07 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001 per share
M - Exercise X 35.000 59.000 145,83 0,51 17.850 30.090
2014-02-12 2014-02-10 4 EPZM Epizyme, Inc.
Stock Option (Right to Buy)
M - Exercise -20.000 292.459 -6,40
2014-02-12 2014-02-10 4 EPZM Epizyme, Inc.
Stock Option (Right to Buy)
M - Exercise -50.000 260.833 -16,09
2014-02-12 2014-02-10 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001 per share
S - Sale -50.000 24.000 -67,57 29,25 -1.462.500 702.000
2014-02-12 2014-02-10 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001 per share
M - Exercise 20.000 74.000 37,04 0,51 10.200 37.740
2014-02-12 2014-02-10 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001 per share
M - Exercise 50.000 54.000 1.250,00 3,54 177.000 191.160
2014-01-30 2014-01-28 4 EPZM Epizyme, Inc.
Stock Option (Right to Buy)
A - Award 27.406 27.406
2014-01-06 2014-01-06 4 EPZM Epizyme, Inc.
Stock Option (Right to Buy)
M - Exercise X -14.000 312.459 -4,29
2014-01-06 2014-01-06 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001 per share
S - Sale X -10.000 4.000 -71,43 20,19 -201.874 80.750
2014-01-06 2014-01-06 4 EPZM Epizyme, Inc.
Common Stock, par value $0.0001 per share
M - Exercise X 14.000 14.000 0,51 7.140 7.140
2013-07-03 2013-07-01 4 EPZM Epizyme, Inc.
Stock Option (Right to Buy)
A - Award 50.000 50.000
P
Acquisto sul mercato aperto o privato di un titolo non derivato o derivato
S
Vendita sul mercato aperto o privato di un titolo non derivato o derivato
A
Concessione, assegnazione o altra acquisizione di titoli dall'azienda (ad esempio un'opzione)
C
Conversione di un derivato
D
Vendita o trasferimento di titoli alla società
F
Pagamento del prezzo di esercizio o del debito fiscale con la quota di titoli ricevuta dalla società
G
Regalo di titoli da parte o a favore dell'insider
K
Equity swap e operazioni di copertura analoghe
M
Esercizio o conversione di un titolo derivato ricevuto dall'azienda (ad esempio un'opzione)
V
Una transazione dichiarata volontariamente sul modulo 4
J
Altro (accompagnato da una nota a piè di pagina che descriva l'operazione)